Navigation Links
SNM releases new fact sheet on breast cancer and molecular imaging
Date:10/3/2008

RESTON, Va.Coinciding with the observance of Nuclear Medicine Week (October 5 to 11) and National Breast Cancer Awareness Month (October), SNM released today a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated.

Molecular imaging is a highly effective, safe and painless imaging tool for diagnosing and treating breast cancer. Physicians report that the information they have gained from molecular imaging technologies has resulted in decisions to change the course of treatment in between 24 and 48 percent of breast cancer cases.

Breast cancer is just one of many types of cancer for which new and emerging molecular imaging techniques and therapies can significantly improve detection, diagnosis and treatment.

"As a field, molecular imaging is evolving very rapidly," said SNM President Robert W. Atcher, Ph.D., M.B.A. "Each new discoverywhether through improved cancer diagnosis and treatment, increased understanding of the fundamental causes of Alzheimer's disease or strides in how we treat cardiovascular diseasebrings personalized medicine one step closer to reality. Molecular imaging techniques and therapies allow us to understand what is happening at a cellular level. Physicians can actually see the precise location of disease, determine if other organs are being affected and then target treatment. It is about delivering the right treatment to the right patient at the right time."

Molecular imaging has the power to:

  • Diagnose cancer early onat its most curable stage;
  • Create a portrait of what cells are doing and how they function over time;
  • Eliminate the need for unnecessary exploratory surgery or multiple surgeries;
  • Provide a painless and cost-effective alternative to more expensiveand less accuratediagnostic tests;
  • Confirm and treat suspected recurrent canc
    '/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. EPA releases report on climate change and health
4. EPA releases science assessment on health effects of nitrogen oxides
5. Pioneering landscape-scale research releases first findings
6. Wildlife Conservation Society releases definitive state of the wild
7. DOE JGI releases a new version of its metagenome data management and analysis system
8. DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts
9. WHRC releases 4 key reports
10. University of Minnesota releases first ever comprehensive report of the health of college students
11. Toxic releases down from North American industry leaders, increasing from other facilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
(Date:11/24/2009)...and the American College of Medical Toxicology (AC... publication of the Journal of Medical Toxicology...ng in March 2010. It was previously published by ...urnal of Medical Toxicology , an international, pe... science and practice of medical toxicology. The ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3American Joint Replacement Registry Announced 52562 1American Joint Replacement Registry Announced 52562 2
...entified a key signaling molecule in the brain tha...g for cocaine. Their finding could offer an import...ircuiting that adaptive process. , In an article i...o Bonci and colleagues established that a short pr... region central to the adaptation to addictive dru...
...s shed more light on the multi-decade debate about...ng at them. , You don,t have to watch your legs an...are. For decades scientists have debated two optio...flow hypothesis says that the brain monitors signa...ly to contract, and uses this to predict where the...
...d "peak fish" and fishermen,s nets will be hauling...l action to stem the global tide of over fishing, ... British Columbia. Dr. Daniel Pauly says the crisi...c proof than about attitude and political will. ,...gh-profile political champion like a Bono or Mande...
Other Biology News:How the brain learns to become addicted 2How does the brain know what the right hand is doing? 2Hooked on fishing, and we're heading for the bottom, says scientist 2Hooked on fishing, and we're heading for the bottom, says scientist 3
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced the approval of all of its,"f... the District of Delaware,(the "Bankruptcy Court")...relief under Chapter 11 of the United States Bankr...he orders issued by the Bankruptcy Court allow the...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
(Date:11/24/2009)...imary efficacy endpoint has been met for patients ...ancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fir...SX: AEZ) (the "Company"), a global biopharmaceutic...gy, today announced positive efficacy data from a ...conjugate, AEZS-108 (formerly AN-152), in patients...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...TON BEACH, California, and AMSTERDAM, May 28 ,Agen...s, today announced its,strong support of Genentech...ocket No. FDA-2008-P-0638-0001/CP petitions that a... scientific and regulatory standards. In response,...er of support to the U.S.,Food and Drug Administra...
...France, May 28 Poxel is a research integrated,pha...erono a division of,Merck KGaA, Germany, following...in diabetes research and development. It aims to a...ses (with a primary focus on Type 2,diabetes) from...fore,out-licensing these projects to major pharmac...
...G, Md., May 28 GenVec, Inc. (Nasdaq: GNVC ) a... agreement with a single institutional investor fo... and warrants to purchase 9,615,385 shares of its ...ants are being offered in units consisting of one ...e share of common stock at a price of $0.624 per u...
Other Biology Technology:Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards 2Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 3
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
5x C'GATE STOCK STABILIZING REAGENT from AbD Serotec
Biology Products: